SOPHARMA AD: Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 22 December 2023

2024-01-02 11:57

publikacja
2024-01-02 11:57

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Donev_Sopharma_EN_Buy_22122023.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		254	/	2023
Date of issue:	2024-01-02
Short name of the issuer
SOPHARMA AD
Subject
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 22 December 2023
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 22 December 2023
Annexes
File			Description
Donev_Sopharma_EN_Buy_22122023.pdfDonev_Sopharma_EN_Buy_22122023.pdf			Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 22 December 2023

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2024-01-02	Ognian Donev	Executive director

Ważne linki